Centre Médical des Monts de Flandre
- Address
- 49, bis rue de Neuve-Église, 59270 Bailleul, France
Centre Médical des Monts de Flandre - Alzheimer's Disease Research
The Centre Médical des Monts de Flandre is dedicated to advancing the understanding and treatment of neurodegenerative disorders, with a particular focus on Alzheimer's disease. The center participates in innovative clinical research exploring novel therapeutic approaches for cognitive decline in dementia patients, ranging from early to moderate disease stages.
- Cognitive function and decline assessment in Alzheimer's disease
- Pharmacological interventions for dementia management
- Early-to-moderate stage Alzheimer's disease treatment strategies
Through participation in multicenter randomized controlled trials, the center contributes to evidence-based research evaluating cognitive outcomes and therapeutic efficacy in patients with MMSE scores between 16 and 26. This commitment to rigorous clinical investigation positions the center as an important contributor to neurodegenerative disease research in the region.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Médical des Monts de Flandre
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled Study on the Efficacy of Caffeine in Cognitive Decline in Early to Moderate Alzheimer's Disease | Centre Hospitalier Universitaire De Lille | Phase III | Recruiting | Oct 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Caffeine | 1 | Unknown | 2024-10-31 | 2024-10-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.